(Morning News) Israeli uses a new guideline to use the use of fast antigen detection reagents, requiring the public to collect samples from the throat and nose when conducting self -testingProbability of the plant.This suggestion in Israel is contrary to the suggestions of the US Food and Drug Administration (FDA).
Reuters reported that Israeli chief public health officer Alroy Price said on Monday (January 10) in an interview with Radio Israeli Military Radio that the rapid antigen test was found to be sensitive to the coronary virus virusIn terms of degree, not comparable to polymerase chain reaction (PCR).
She said: "In order to increase the probability of discovering the virus, we now suggest that the public conducts the test of throat and nose swabs at the same time. This is not the instruction of the use of the reagent producer, but we want everyone to do so. "
The Israeli Ministry of Health issued a new guideline afterwards, indicating that the sample should be collected first from the throat when using the fast antigen detection, and then the sample is collected from a nostril.
Israeli crown disease responding to coordinator Zaka said at a press conference on the day that this will help improve the reliability of the test results.The Israeli health department will post a video to guide the public how to use this new collection sample method correctly.
The US Food and Drug Administration requires the public to perform self -test according to the use of the user's manual of the fast antigen detection reagent producer, and pointed out that the improper throat detection method may constitute a safety risk.
